author-photo

Hongmei Mo

Queen Mary University of London

185

Papers

8555

Citations

Citation Trend

Filter By

Papers (119) Sort By

Journal Conference Others

Prevalence of Resistance-Associated Substitutions and Phylogenetic Analysis of Hepatitis C Virus Infection in Russia.

2021 International Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir.

2021 Antiviral Research
Show All
- Source
- Cite
- Save
Citations (11)
Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines.

2021 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (1)
Hepatitis B Virus Genome Diversity in Adolescents: Tenofovir Disoproxil Fumarate Treatment Effect and HBeAg Seroconversion.

2021 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (0)
Genetic Conservation of SARS-CoV-2 RNA Replication Complex in Globally Circulating Isolates from Humans and Minks Predicts Minimal Pre-Existing Resistance to Remdesivir

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Developing a sensitive HBV genotyping assay for HBV DNA suppressed patients using both DNA and RNA sequencing.

2020 Journal of Medical Virology
Show All
- Source
- Cite
- Save
Citations (2)
Correction for Han et al., "In Vitro Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3/4A Inhibitor Voxilaprevir".

2020 Journal of Clinical Microbiology
Show All
- Source
- Cite
- Save
Citations (1)
Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistance.

2020 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (2)
Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial

2019 The Lancet Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (57)
In Vitro Resistance Profile of Hepatitis C Virus NS 5A Inhibitor Velpatasvir in Genotypes 1 to 6

2019 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (11)